MX2012004673A - Composiciones farmaceuticas de combinaciones de inhibidores de dipeptidil peptidasa 4 con pioglitazona. - Google Patents
Composiciones farmaceuticas de combinaciones de inhibidores de dipeptidil peptidasa 4 con pioglitazona.Info
- Publication number
- MX2012004673A MX2012004673A MX2012004673A MX2012004673A MX2012004673A MX 2012004673 A MX2012004673 A MX 2012004673A MX 2012004673 A MX2012004673 A MX 2012004673A MX 2012004673 A MX2012004673 A MX 2012004673A MX 2012004673 A MX2012004673 A MX 2012004673A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- pioglitazone
- combinations
- dipeptidyl peptidase
- inhibitors
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 title abstract 4
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 title abstract 2
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 title abstract 2
- 229960005095 pioglitazone Drugs 0.000 title abstract 2
- 229940000425 combination drug Drugs 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25429909P | 2009-10-23 | 2009-10-23 | |
| PCT/US2010/052225 WO2011049773A1 (en) | 2009-10-23 | 2010-10-12 | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012004673A true MX2012004673A (es) | 2012-06-14 |
Family
ID=43900618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012004673A MX2012004673A (es) | 2009-10-23 | 2010-10-12 | Composiciones farmaceuticas de combinaciones de inhibidores de dipeptidil peptidasa 4 con pioglitazona. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120201885A1 (enExample) |
| EP (1) | EP2490534A4 (enExample) |
| JP (1) | JP2013508370A (enExample) |
| KR (1) | KR20120104523A (enExample) |
| CN (1) | CN102573476A (enExample) |
| AU (1) | AU2010308433A1 (enExample) |
| BR (1) | BR112012009496A2 (enExample) |
| CA (1) | CA2777231A1 (enExample) |
| IN (1) | IN2012DN03271A (enExample) |
| MX (1) | MX2012004673A (enExample) |
| RU (1) | RU2012121185A (enExample) |
| WO (1) | WO2011049773A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR086675A1 (es) * | 2011-06-14 | 2014-01-15 | Merck Sharp & Dohme | Composiciones farmaceuticas de combinaciones de inhibidores de la dipeptidil peptidasa-4 con simvastatina |
| US20140248345A1 (en) * | 2011-10-24 | 2014-09-04 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with atorvastatin |
| MX370175B (es) * | 2013-03-06 | 2019-12-04 | Novartis Ag | Formulaciones de compuestos orgánicos. |
| US9937153B2 (en) * | 2013-08-30 | 2018-04-10 | Merck Sharp & Dohme Ltd. | Oral pharmaceutical formulation of omarigliptin |
| TR201402685A1 (tr) * | 2014-03-06 | 2015-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Vildagliptinin farmasotik formulasyonları. |
| CN105030724A (zh) * | 2015-08-20 | 2015-11-11 | 杭州成邦医药科技有限公司 | 一种抗糖尿病药物的组合物 |
| CN108096227A (zh) * | 2018-01-25 | 2018-06-01 | 河北科技大学 | 阿格列汀口腔溶膜制剂 |
| JP7109748B2 (ja) * | 2018-12-11 | 2022-08-01 | 日本ジェネリック株式会社 | アジルサルタンとアムロジピンベシル酸塩含有固形製剤及び固形製剤の製造方法 |
| JP7423264B2 (ja) * | 2019-10-17 | 2024-01-29 | 日本ジェネリック株式会社 | シタグリプチン含有錠剤 |
| WO2022074664A1 (en) * | 2020-10-05 | 2022-04-14 | V-Ensure Pharma Technologies Private Limited | An immediate release composition of sitagliptin hydrochloride |
| TR202022612A2 (tr) * | 2020-12-31 | 2022-07-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Alogli̇pti̇ni̇n farmasöti̇k kapsül kompozi̇syonlari |
| CN115227661B (zh) * | 2022-09-22 | 2022-12-13 | 北京惠之衡生物科技有限公司 | 一种利格列汀片及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0014969D0 (en) * | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| CN101035522B (zh) * | 2004-10-25 | 2011-12-07 | 诺瓦提斯公司 | Dpp-ⅳ抑制剂、ppar抗糖尿病剂和二甲双胍的组合 |
| MY152185A (en) * | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| CN101208085B (zh) * | 2005-06-10 | 2011-01-05 | 诺瓦提斯公司 | 1-[(3-羟基-金刚烷基-1-基氨基)-乙酰基]-吡咯烷基-2(s)-腈的调释制剂 |
| JOP20180109A1 (ar) * | 2005-09-29 | 2019-01-30 | Novartis Ag | تركيبة جديدة |
| AR071175A1 (es) * | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
-
2010
- 2010-10-12 WO PCT/US2010/052225 patent/WO2011049773A1/en not_active Ceased
- 2010-10-12 BR BR112012009496A patent/BR112012009496A2/pt not_active IP Right Cessation
- 2010-10-12 EP EP10825413.7A patent/EP2490534A4/en not_active Withdrawn
- 2010-10-12 CA CA2777231A patent/CA2777231A1/en not_active Abandoned
- 2010-10-12 JP JP2012535230A patent/JP2013508370A/ja not_active Withdrawn
- 2010-10-12 MX MX2012004673A patent/MX2012004673A/es unknown
- 2010-10-12 IN IN3271DEN2012 patent/IN2012DN03271A/en unknown
- 2010-10-12 RU RU2012121185/13A patent/RU2012121185A/ru not_active Application Discontinuation
- 2010-10-12 KR KR1020127010201A patent/KR20120104523A/ko not_active Withdrawn
- 2010-10-12 CN CN2010800477129A patent/CN102573476A/zh active Pending
- 2010-10-12 US US13/501,252 patent/US20120201885A1/en not_active Abandoned
- 2010-10-12 AU AU2010308433A patent/AU2010308433A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120104523A (ko) | 2012-09-21 |
| AU2010308433A1 (en) | 2012-06-07 |
| EP2490534A1 (en) | 2012-08-29 |
| US20120201885A1 (en) | 2012-08-09 |
| CN102573476A (zh) | 2012-07-11 |
| WO2011049773A1 (en) | 2011-04-28 |
| IN2012DN03271A (enExample) | 2015-10-23 |
| BR112012009496A2 (pt) | 2015-09-29 |
| RU2012121185A (ru) | 2013-11-27 |
| CA2777231A1 (en) | 2011-04-28 |
| EP2490534A4 (en) | 2013-06-12 |
| JP2013508370A (ja) | 2013-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012004673A (es) | Composiciones farmaceuticas de combinaciones de inhibidores de dipeptidil peptidasa 4 con pioglitazona. | |
| IL212485A0 (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| WO2009155001A3 (en) | Wnt protein signalling inhibitors | |
| HUS1400009I1 (hu) | Dipeptidil peptidáz inhibitorok adagolása | |
| PL2247602T3 (pl) | Pochodne O-glukuronido-adamantylowe jako inhibitory dipeptydylopeptydazy IV do leczenia cukrzycy | |
| MX2012002633A (es) | Aminotetrahidropiranos como inhibidores de la dipeptidil peptidasa iv para el tratamiento prevencion de la diabetes. | |
| EA201270520A1 (ru) | Новые соединения, эффективные в качестве ингибиторов ксантиноксидазы, способ их получения и содержащая их фармацевтическая композиция | |
| MY148496A (en) | Dpp iv inhibitor formulations | |
| WO2009117421A3 (en) | Heterocyclic modulators of gpr119 for treatment of disease | |
| PH12012500632B1 (en) | Pharmaceutical compositions comprising bi-1356 and metformin | |
| MY160456A (en) | Benzodiazepine bromodomain inhibitor | |
| ZA200807488B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | |
| IL200653A0 (en) | Weekly administration of dipeptidyl peptidase inhibitors | |
| WO2009111239A3 (en) | Pyrrolidine derivatives | |
| WO2013062902A3 (en) | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with atorvastatin | |
| EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
| AU2010353685A8 (en) | Novel glucagon like peptide analogs, composition, and method of use | |
| IL213105A0 (en) | Dipeptidyl peptidase iv inhibitors | |
| ZA200808188B (en) | Novel dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them | |
| WO2013006526A3 (en) | Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors | |
| WO2009111078A3 (en) | Combination of a ppary agonist and a dipeptidyl peptidase-inhibitor for the treatment of diabetes and obesity | |
| MX2013002503A (es) | Combinacion de inhibidores de hdac con farmacos para trombocitopenia. | |
| WO2010075086A3 (en) | Pyrrolidinone inhibitors of pde-4 | |
| AU2010298020A8 (en) | Combination | |
| WO2010023197A3 (en) | Piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights | ||
| HC | Change of company name or juridical status |